Holistic Technologies Inc., was founded in 2018 to develop and market opioid-free pain management products and technologies.
Our mission is to improve the lives of patients with chronic pain through technological innovation and compassionate care.
The Allevetech's proprietary technology offers safe and cost-effective pain management solutions, alternative to currently available treatments.
Over 130M Americans suffer from chronic pain; 1.5B globally.
The use of opioids is deemed to be the most pressing crisis in modern history claiming over 800,000 lives in the U.S. alone, and creating a demand for alternative pain management solutions.
The size of the pain management market is over $87B with a CAGR of 7.39% through 2027.
Pain is the largest healthcare expenditure in the U.S., Canada and Europe.
The annual economic cost of chronic pain in the U.S. alone is over $600B.
Public and private participants are continuously seeking cost-effective, low-risk pain management solutions.
Pain is the largest healthcare expenditure in the US, Canada and Europe.
The average cost of treating pain is $6,096 per patient.
The cost of treating chronic pain is $32,000 per year per patient.
The annual economic cost of chronic pain in the United States alone is estimated to be over USD 635B.
The opioid epidemic in the U.S. claimed to date over 800,000 American lives, which is more than the War of Independence, WW I, WW II, Vietnam, Korea, Iraq and Afghanistan combined.
18% of the adult population in North America are prescribed opioids.
19% of patients prescribed opioids develop an opioid-use disorder.
80% of heroin addicts started with prescription opioids.
75% of all drug overdoses in North America are opioid-related.
The CDC alongside the Joint Action Committee estimated the overall cost of the opioid pandemic to be $1.5T in 2020 in the USA.
At Holistic Technologies, we believe that medical research needs to focus on finding ways to treat the cause of chronic pain, not just the symptoms.
Our goal is to offer safe, non-invasive, innovative solutions for treating chronic pain to increase the quality of life of every patient.
Zbigniew (Zib ) Kozak, Co-founder and CEO
Zib has worked in various roles as a consultant ranging from authoring the Environmental Stewardship project in the mining industry to being a leading member in developing risk and security assessments for the FIFA World Cup and the Summer and Winter Olympic Games sponsors. Zib also played a vital role in launching two European brands, Elaspa and Elapromed, in the beauty and wellness sector in Canada.
Barbara Krutchkoff, PhD
Dr. Krutchkoff is an Executive Director of the Institute of Regenerative and Cellular Medicine and Co-Chair of the IRB, which focuses on translational research for regenerative therapeutics. In a span of decades, Barbara has provided strategic assistance for numerous biotech entrepreneurs to help validate novel technologies and therapeutic modalities as well as navigate the regulatory pathway to bring them safely to patients. Currently serving as Chief Scientific Officer, she leads an innovation team at Moda Health, an insurance company looking to reinvent healthcare.
We have developed several strategic relationships with top educational institutions, scientists, and distributors.
We invite practitioners, the scientific community, public organizations, investors and non-profit organizations to work and collaborate with us in bringing safe and clinically tested technology to address one of the most pressing social issues in modern history.
Zbigniew (Zib) Kozak
778 379 0330
201-1537 West 8th Ave.
Vancouver, BC V6J 1T5 Canada
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.